Literature DB >> 26205479

Ambulatory Blood Pressures in Hypertensive Patients Treated With One Antihypertensive Agent: Differences Among Drug Classes and Among Drugs Belonging to the Same Class.

Alejandro de la Sierra1, Manuel Gorostidi2, José R Banegas3, Julián Segura4, Ernest Vinyoles5, Juan J de la Cruz3, Luis M Ruilope4.   

Abstract

The authors investigated the differences in office and ambulatory blood pressure (BP) among major antihypertensive drug classes and among frequently used drugs in each class in 22,617 patients treated with monotherapy from the Spanish ABPM Registry. Using thiazides as the reference group, patients treated with calcium channel blockers have significantly (P<.01) elevated ambulatory BP and less ambulatory control after adjusting for confounders. Inside each class, no significant differences were observed among thiazides or angiotensin receptor blockers. Atenolol and bisoprolol among β-blockers, amlodipine among calcium channel blockers, and lisinopril and enalapril among angiotensin-converting enzyme inhibitors exhibited lower ambulatory BP and better control than other agents. Differences exist among antihypertensive drug classes and among different compounds in each class with respect to ambulatory BP control. This can help physicians choose among drug classes and among compounds in each class if BP reduction is the main objective of treatment.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26205479      PMCID: PMC8031878          DOI: 10.1111/jch.12623

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  16 in total

1.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

Review 2.  Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force.

Authors:  Margaret A Piper; Corinne V Evans; Brittany U Burda; Karen L Margolis; Elizabeth O'Connor; Evelyn P Whitlock
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

3.  Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.

Authors:  Alejandro de la Sierra; José R Banegas; Anna Oliveras; Manuel Gorostidi; Julián Segura; Juan J de la Cruz; Pedro Armario; Luis M Ruilope
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

4.  Office and 24-h ambulatory blood pressure control by treatment in general practice: the 'Monitoraggio della pressione ARteriosa nella medicina TErritoriale' study.

Authors:  Augusto Zaninelli; Gianfranco Parati; Claudio Cricelli; Angelo A Bignamini; Pietro A Modesti; Franco Pamparana; Grzegorz Bilo; Giuseppe Mancia; Gian F Gensini
Journal:  J Hypertens       Date:  2010-05       Impact factor: 4.844

5.  Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.

Authors:  Alejandro de la Sierra; Josep Redon; José R Banegas; Julián Segura; Gianfranco Parati; Manuel Gorostidi; Juan J de la Cruz; Javier Sobrino; José L Llisterri; Javier Alonso; Ernest Vinyoles; Vicente Pallarés; Antonio Sarría; Pedro Aranda; Luis M Ruilope
Journal:  Hypertension       Date:  2009-01-26       Impact factor: 10.190

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

8.  Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  B J Materson; D J Reda; W C Cushman; B M Massie; E D Freis; M S Kochar; R J Hamburger; C Fye; R Lakshman; J Gottdiener
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

9.  Ambulatory Blood Pressures in Hypertensive Patients Treated With One Antihypertensive Agent: Differences Among Drug Classes and Among Drugs Belonging to the Same Class.

Authors:  Alejandro de la Sierra; Manuel Gorostidi; José R Banegas; Julián Segura; Ernest Vinyoles; Juan J de la Cruz; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-24       Impact factor: 3.738

Review 10.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19
View more
  4 in total

1.  Insights into nocturnal blood pressure.

Authors:  Maeve D'Alton; Eamon Dolan
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-05       Impact factor: 3.738

2.  Efficacy of Antihypertensive Monotherapies Assessed by Ambulatory Blood Pressure Monitoring: Is There Really a Winner?

Authors:  Bernard Waeber; François Feihl
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-24       Impact factor: 3.738

3.  Ambulatory Blood Pressures in Hypertensive Patients Treated With One Antihypertensive Agent: Differences Among Drug Classes and Among Drugs Belonging to the Same Class.

Authors:  Alejandro de la Sierra; Manuel Gorostidi; José R Banegas; Julián Segura; Ernest Vinyoles; Juan J de la Cruz; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-24       Impact factor: 3.738

4.  Twenty-four-hour ambulatory blood pressure changes in older patients with essential hypertension receiving monotherapy or dual combination antihypertensive drug therapy.

Authors:  Pei-Pei Lu; Xu Meng; Ying Zhang; Yan-Qi Li; Shu Wang; Li-Sheng Liu; Wen Wang; Yu-Ling Li; Yu-Qing Zhang; Ai-Hua Hu; Xian-Liang Zhou; Li-Hong Ma
Journal:  J Geriatr Cardiol       Date:  2019-04       Impact factor: 3.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.